Evidence map›Paper›PMID 31297663›Full record

ArticleNeurocritical care2020

Dysautonomia in Guillain-Barré Syndrome: Prevalence, Clinical Spectrum, and Outcomes.

Tia Chakraborty, Christopher L Kramer, Eelco F M Wijdicks, Alejandro A Rabinstein

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Neurocritical care, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05230641 (Cardiac Autonomic Dysfunction and Perioperative Outcomes After Neurosurgery), which is not on this map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
6.3field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05230641 completednot on this mapstarted 2022, after this paper: background citation

Cardiac Autonomic Dysfunction and Perioperative Outcomes After Neurosurgery

TypeobservationalSponsorNational Institute of Mental Health and Neuro Sciences, IndiaRan2022 to 2023Enrolled400ConditionsNeurosurgical PatientsArmsNo intervention
3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 121 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Prognostic value of modified Erasmus Guillaiun Barre' syndrome outcome score (mEGOS) in an Italian cohort of patients: Challenges, insights and limitations.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2026
    Article
  5. Article
  6. Acute Urinary Retention and Guillain-Barré Syndrome: A Zebra or a Horse.Journal of the American College of Emergency Physicians open · 2026
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Guillain-Barré syndrome.BJA education · 2025
    Review
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Tia ChakrabortyMayo Clinic Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA. Chakraborty.Tia@mayo.edu.ORCID http://orcid.org/0000-0001-7395-8592
Christopher L KramerDepartment of Neurology, The University of Chicago, Chicago, IL, USA.
Eelco F M WijdicksMayo Clinic Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Alejandro A RabinsteinMayo Clinic Department of Neurology, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Mayo Clinic · USUniversity of Chicago · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGuillain-Barré syndrome (GBS), when severe, involves the autonomic nervous system; our objective was to assess the spectrum and predictors of dysautonomia, and how it may impact functional outcomes.

methodsA retrospective review of patients admitted to the Mayo Clinic in Rochester, MN between January 1, 2000, and December 31, 2017, with GBS and dysautonomia was performed. Demographics, comorbidities, parameters of dysautonomia, clinical course, GBS disability score, and Erasmus GBS Outcome Score (EGOS) at discharge were recorded.

resultsOne hundred eighty seven patients were included with 71 (38%) noted to have at least one manifestation of dysautonomia. There are 72% of patients with a demyelinating form of GBS and 36% of patients with demyelination had dysautonomia. Ileus (42%), hypertension (39%), hypotension (37%), fever (29%), tachycardia or bradycardia (27%), and urinary retention (24%) were the most common features. Quadriparesis, bulbar and neck flexor weakness, and mechanical ventilation were associated with autonomic dysfunction. Patients with dysautonomia more commonly had cardiogenic complications, syndrome of inappropriate antidiuretic hormone, posterior reversible encephalopathy syndrome, and higher GBS disability score and EGOS. Mortality was 6% in patients with dysautonomia versus 2% in the entire cohort (P = 0.02).

conclusionsDysautonomia in GBS is a manifestation of more severe involvement of the peripheral nervous system. Accordingly, mortality and functional outcomes are worse. There is a need to investigate if more aggressive treatment is warranted in this category of GBS.

Indexed as

Hospital MortalityAdultAgedBradycardiaFemaleFeverGuillain-Barre SyndromeHumansHypertensionHypotensionIleusImmunoglobulins, IntravenousImmunologic FactorsInappropriate ADH SyndromeMaleMiddle AgedImmunoglobulins, IntravenousImmunologic FactorsAcute inflammatory demyelinating polyradiculoneuropathyAutonomic dysfunctionDysautonomiaGuillain–Barré syndrome

Identifiers

PMID31297663
OpenAlexW2956911396

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.